DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?
Veriheal
JANUARY 24, 2023
But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. Could our society miss out on potential medical breakthroughs due to outdated marijuana laws or strict regulations? In the saga of prohibition, here’s the latest news.
Let's personalize your content